Selected article for: "ace expression and acute respiratory"
Author: Dean, Alexis Q.; Bozza, William P.; Twomey, Julianne D.; Luo, Shen; Nalli, Ancy; Zhang, Baolin
Title: The fight against COVID-19: striking a balance in the renin–angiotensin system
  • Cord-id: iho6kokg
  • Document date: 2021_4_15
    • ID: iho6kokg
    Snippet: The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters host cells by interacting with membrane-bound angiotensin-converting enzyme 2 (ACE2), a vital element in the renin–angiotensin system (RAS), which regulates blood pressure, fluid balance, and cardiovascular functions. We herein evaluate existing evidence for the molecular alterations within the RAS pathway (e.g., ACE2 and angiotensin II) during SARS-CoV-2 infection and subsequent Coronavirus 2019 (COVID-1
    Document: The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters host cells by interacting with membrane-bound angiotensin-converting enzyme 2 (ACE2), a vital element in the renin–angiotensin system (RAS), which regulates blood pressure, fluid balance, and cardiovascular functions. We herein evaluate existing evidence for the molecular alterations within the RAS pathway (e.g., ACE2 and angiotensin II) during SARS-CoV-2 infection and subsequent Coronavirus 2019 (COVID-19). This includes reports regarding potential effect of RAS blockade (e.g., ACE inhibitors and angiotensin II receptor blockers) on ACE2 expression and clinical outcomes in patients with co-morbidities commonly treated with these agents. The collective evidence suggests a dual role for ACE2 in COVID-19, depending on the stage of infection and the coexisting diseases in individual patients. This information is further discussed with respect to potential therapeutic strategies targeting RAS for COVID-19 treatment.

    Search related documents:
    Co phrase search for related documents
    • acei arb therapy and lung injury: 1, 2
    • acei arb therapy and lung kidney: 1
    • acei arb treatment and lung alveolar: 1, 2
    • acei arb treatment and lung injury: 1, 2, 3
    • acei arb treatment and lung kidney: 1
    • acute pancreatitis and additional study: 1, 2
    • acute pancreatitis and lung alveolar: 1, 2
    • acute pancreatitis and lung injury: 1, 2, 3, 4, 5, 6, 7
    • acute pancreatitis and lung kidney: 1, 2, 3
    • acute pancreatitis and lung kidney heart: 1, 2
    • additional study and lung injury: 1, 2